Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
about
Understanding the regulation of Group B Streptococcal virulence factorsGroup B streptococcal neuraminidase is actually a hyaluronidase.Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal diseaseProduction of bacteremia and meningitis in infant rats with group B streptococcal serotypes.Properties of a hemolysin produced by group B streptococciAssociation of type- and group-specific antigens with the cell wall of serotype III group B streptococcusFactors influencing adherence of group B streptococci to human vaginal epithelial cellsPurification and partial characterization of neuraminidase from type III group B streptococci.Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinantsPopulation structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease.Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.Variations in the opsonic requirements of group B streptococcus type III.Molecular analysis of lipoteichoic acid from Streptococcus agalactiae.Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan.Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci.Lysis of erythrocytes by a hemolysin produced by a group B Streptococcus sp.Factors influencing release of type III antigens by group B streptococci.Neuraminidase activity of Pasteurella haemolytica isolatesDeposition and degradation of C3 on type III group B streptococci.Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III diseaseIn vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patientsIdentification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40 degrees C.Protease production by clinical isolates of type III group B streptococci.Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.Alterations of the Erythrocyte Membrane during SepsisCharacterization of neuraminidases produced by various serotypes of group B streptococci.Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.Neuraminidase production by a Pasteurella haemolytica A1 strain associated with bovine pneumonia.
P2860
Q28237019-2ADCA401-C47F-426E-BBCA-620D417EB719Q33604365-A1AD0E12-44EF-4063-A7C7-109B310D6C0AQ33864281-9BB8BB03-4945-48FB-B5DE-52F95925B202Q33901368-E81DD603-28CB-4B1A-8E74-F94CD12A7CFFQ33911531-8BF715EF-0385-4B63-9CB2-680F5EF0C6D6Q33912849-E7526B06-5BDD-4D38-B0AA-B2FFE9E0E552Q34096478-AC3EB027-5048-4F14-B14C-1FE6F6048927Q34157435-A99AD63F-8B1E-438A-BCE5-7AA175A1345BQ35073801-651A326D-5876-49DD-AF0A-9663951013F1Q35475084-09AA8DAE-72A5-430C-9CE7-2892F73D73D3Q36090468-F9A2D932-03CD-4C18-8E0E-1DD5FD17BCC0Q36091664-7A599E17-34F3-4A24-B911-118361A266D9Q36125392-C7895039-962B-48F0-944A-3A3A916E7995Q36382419-69A6925B-105D-4EB3-AA8D-11B591EE5283Q36430428-F99B99A1-EE35-4696-B18C-B799DEA7DA4AQ36430672-6D03327A-C1AA-4E62-8CB6-33BFFB372481Q36431896-6F4192F4-B8B4-4B6B-8498-6762FB4DF40AQ36442409-44924943-4DBC-45C7-B842-170289C88429Q36448867-9B4A7DE3-4BC3-4084-83F4-F8633AFAF241Q36964654-83E3F96D-03B3-4B35-BABB-0F9B5BBE1080Q37081296-5BDF79F2-7910-4A26-B08C-BB921CC37574Q37147074-511FCCFB-E25D-4D61-990E-8EEFDD62DCECQ37187052-8C20209B-7D44-4E6A-94BF-A2586838F810Q37328631-40EBC078-1BE8-4DCC-94EA-39788AFE5B4EQ37329956-AE2417D5-FA59-459F-B90E-6FDF5D576473Q38016896-B7AD5CC4-8AEE-4E01-B87E-2E26018AEF61Q40162198-46A69013-EEB8-465F-921B-7EA7C65CD5F2Q40182698-4397D33D-7D4A-4F7C-9187-A1F62BF68AF8Q40373704-0D9B0C12-4FBB-4984-8014-B0D4D63A6250
P2860
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
description
1978 nî lūn-bûn
@nan
1978 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Association of elevated levels ...... type III group B streptococci.
@ast
Association of elevated levels ...... type III group B streptococci.
@en
Association of elevated levels ...... type III group B streptococci.
@nl
type
label
Association of elevated levels ...... type III group B streptococci.
@ast
Association of elevated levels ...... type III group B streptococci.
@en
Association of elevated levels ...... type III group B streptococci.
@nl
prefLabel
Association of elevated levels ...... type III group B streptococci.
@ast
Association of elevated levels ...... type III group B streptococci.
@en
Association of elevated levels ...... type III group B streptococci.
@nl
P2093
P2860
P1476
Association of elevated levels ...... type III group B streptococci.
@en
P2093
Mattingly SJ
Milligan TW
P2860
P304
P407
P577
1978-09-01T00:00:00Z